We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sanofi Defends Validity Of Pen Injector Patent Before Patent Board

Mealey's (June 26, 2019, 1:39 PM EDT) -- ALEXANDRIA, Va. — In a June 25 filing with the Patent Trial and Appeal Board, Sanofi-Aventis Deutschland GMBH pointed to the “overwhelming” commercial success of its “LANTUS® SoloSTAR®” pen injector as...
To view the full article, register now.